Remicade “Black Box” Warning On Risk Of Lymphoma Added To Label
This article was originally published in The Pink Sheet Daily
Executive Summary
J&J/Centocor cite six reports of hepatosplenic T-cell lymphoma post-marketing in patients taking concomitant immunosuppressants.